Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
sarepta therapeutics
4
×
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cystic fibrosis
duchenne muscular dystrophy
roche
spark therapeutics
vertex pharmaceuticals
10x genomics
abbvie
acute myeloid leukemia
What
fda
4
×
bio
drugs
roundup
gene
news
therapy
won
ahead
approval
aren’t
asco
august
betting
billion
biopharma
biotech
branded
busy
choices
commissioner
consumers
costly
counterweight
days
deal
decisions
developers
devices
drug
duchenne
elevatebio
generic
graft
help
historic
imminent
legacy
long
medicare
Language
unset
Current search:
fda
×
" sarepta therapeutics "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More